Search Results - "Thirusangu, Prabhu"

Refine Results
  1. 1

    Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer by Xiao, Yinan, Jin, Ling, Deng, Chaolin, Guan, Ye, Kalogera, Eleftheria, Ray, Upasana, Thirusangu, Prabhu, Staub, Julie, Sarkar Bhattacharya, Sayantani, Xu, Haotian, Fang, Xiaoling, Shridhar, Viji

    Published in Oncogene (25-02-2021)
    “…The advanced or recurrent endometrial cancer (EC) has a poor prognosis because of chemoresistance. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3…”
    Get full text
    Journal Article
  2. 2

    Quinacrine-Induced Autophagy in Ovarian Cancer Triggers Cathepsin-L Mediated Lysosomal/Mitochondrial Membrane Permeabilization and Cell Death by Thirusangu, Prabhu, Pathoulas, Christopher L, Ray, Upasana, Xiao, Yinan, Staub, Julie, Jin, Ling, Khurana, Ashwani, Shridhar, Viji

    Published in Cancers (21-04-2021)
    “…We previously reported that the antimalarial compound quinacrine (QC) induces autophagy in ovarian cancer cells. In the current study, we uncovered that QC…”
    Get full text
    Journal Article
  3. 3

    Synthesis of coumarin analogs appended with quinoline and thiazole moiety and their apoptogenic role against murine ascitic carcinoma by Prashanth, T., Avin, B.R. Vijay, Thirusangu, Prabhu, Ranganatha, V. Lakshmi, Prabhakar, B.T., Sharath Chandra, J.N. Narendra, Khanum, Shaukath Ara

    Published in Biomedicine & pharmacotherapy (01-04-2019)
    “…[Display omitted] •Novel coumarin analogs were synthesized with verity of substituents.•Docking studies have been done for the potent compound 13f.•In vitro…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Anti-neoplastic pharmacophore benzophenone-1 coumarin (BP-1C) targets JAK2 to induce apoptosis in lung cancer by Sherapura, Ankith, Malojirao, Vikas H., Thirusangu, Prabhu, Sharath, B. S., Kandagalla, Shivananda, Vigneshwaran, V., Novak, Jurica, Ranganatha, Lakshmi, Ramachandra, Y. L., Baliga, Shrinath M., Khanum, Shaukath Ara, Prabhakar, B. T.

    Published in Apoptosis (London) (01-02-2022)
    “…Reigning of the abnormal gene activation associated with survival signalling in lung cancer leads to the anomalous growth and therapeutic failure. Targeting…”
    Get full text
    Journal Article
  7. 7

    Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines by Oien, Derek B., Ray, Upasana, Pathoulas, Christopher L., Jin, Ling, Thirusangu, Prabhu, Jung, Deokbeom, Kumka, Joseph E., Xiao, Yinan, Sarkar Bhattacharya, Sayantani, Montoya, Dennis, Chien, Jeremy, Shridhar, Viji

    Published in Cancers (16-09-2021)
    “…A considerable subset of gynecologic cancer patients experience disease recurrence or acquired resistance, which contributes to high mortality rates in ovarian…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Repurposing quinacrine for treatment-refractory cancer by Oien, Derek B., Pathoulas, Christopher L., Ray, Upasana, Thirusangu, Prabhu, Kalogera, Eleftheria, Shridhar, Viji

    Published in Seminars in cancer biology (01-01-2021)
    “…Quinacrine, also known as mepacrine, has originally been used as an antimalarial drug for close to a century, but was recently rediscovered as an anticancer…”
    Get full text
    Journal Article
  12. 12

    Exploiting LRRC15 as a Novel Therapeutic Target in Cancer by Ray, Upasana, Pathoulas, Christopher L, Thirusangu, Prabhu, Purcell, James W, Kannan, Nagarajan, Shridhar, Viji

    Published in Cancer research (Chicago, Ill.) (03-05-2022)
    “…Abundant fibrotic stroma is a typical feature of most solid tumors, and stromal activation promotes oncogenesis, therapy resistance, and metastatic…”
    Get full text
    Journal Article
  13. 13

    PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM by Sarkar Bhattacharya, Sayantani, Thirusangu, Prabhu, Jin, Ling, Staub, Julie, Shridhar, Viji, Molina, Julian R.

    Published in British journal of cancer (19-10-2022)
    “…Background Malignant pleural mesothelioma (MPM) is an aggressive neoplasm and often acquires chemoresistance by increasing stemness in tumour tissue, thereby…”
    Get full text
    Journal Article
  14. 14

    PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma by Thirusangu, Prabhu, Ray, Upasana, Sarkar Bhattacharya, Sayantani, Oien, Derek B., Jin, Ling, Staub, Julie, Kannan, Nagarajan, Molina, Julian R., Shridhar, Viji

    Published in Oncogene (12-08-2022)
    “…PFKFB3 (6-phosphofructo-2-kinase) is the rate-limiting enzyme of glycolysis and is overexpressed in several human cancers that are associated with poor…”
    Get full text
    Journal Article
  15. 15

    Abstract 1936: Autophagy-dependent therapeutic targeting of group III phospholipase A2 attenuates ovarian cancer metastasis by Ray, Upasana, Roy, Debarshi, Jin, Ling, Thirusangu, Prabhu, Staub, Julie, Xiao, Yinan, Shridhar, Viji

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Abstract Objective: Aberrant lipogenicity and deregulated autophagy are common in most advanced human cancer and therapeutic strategies to exploit these…”
    Get full text
    Journal Article
  16. 16

    Abstract 1937: Quinacrine-induced autophagy in ovarian cancer triggers cathepsin-L mediated lysosomal/mitochondrial membrane permeabilization and cell death by Thirusangu, Prabhu, Pathoulas, Christopher L., Ray, Upasana, xiao, Yinan, Staub, Julie, Khurana, Ashwani, Shridhar, Vijayalakshmi

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Abstract Background: Lysosomes are acidic organelles that contain numerous cathepsins and acid hydrolases. Lysosomal membrane permeabilization (LMP) and the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Abstract 1046: Synergistic cytotoxic effect of sulfated glycolipid PG545 in combination with ATR inhibition in ovarian cancer cells by Xiao, Yinan, Deng, Chaolin, Guan, Ye, Jin, Ling, Ray, Upasana, Thirusangu, Prabhu, Staub, Julie, Xu, Haotian, Shridhar, Viji

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Abstract Despite the advances in the molecular understanding of ovarian cancer (OC), improvements in therapy are still needed. PG545 is a highly sulfated small…”
    Get full text
    Journal Article
  19. 19
  20. 20

    PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction by Ray, Upasana, Thirusangu, Prabhu, Jin, Ling, Xiao, Yinan, Pathoulas, Christopher L., Staub, Julie, Erskine, Courtney L., Dredge, Keith, Hammond, Edward, Block, Matthew S., Kaufmann, Scott H., Bakkum-Gamez, Jamie N., Shridhar, Viji

    Published in Oncogene (08-09-2023)
    “…PG545 (Pixatimod) is a highly sulfated small molecule known for its ability to inhibit heparanase and disrupt signaling mediated by heparan-binding-growth…”
    Get full text
    Journal Article